The Journal of Practical Medicine >
The effect of ozone autohemotherapy on serum Lp(a),sleep quality,and heart rate variability in postmenopausal patients with hypercholesterolemia
Received date: 2025-08-06
Online published: 2025-12-25
Objective To investigate the effect of ozone autohemotherapy on serum lipoprotein(a) [Lp(a)],sleep quality,and heart rate variability in postmenopausal patients with hypercholesterolemia. Methods This study is a prospective cohort study. A total of 100 postmenopausal female patients diagnosed with hypercholesterolemia during health check-ups at the South Lake Campus of Wuhan Wuchang Hospital between August 2024 and May 2025 were selected. They were randomly divided into a control group and a treatment group,with 50 patients in each group. Two patients dropped out of the control group,and four patients dropped out of the treatment group. The control group received atorvastatin calcium tablets,while the treatment group received ozone autohemotherapy in addition to the treatment in the control group. The treatment lasted for 10 days per cycle,and both groups were treated and observed for one month. The levels of Lp(a),total cholesterol (CHO),high-density lipoprotein cholesterol (HDL-C),low-density lipoprotein cholesterol (LDL-C),triglycerides (TG),uric acid (UA),homocysteine (Hcy),and fasting plasma glucose (FPG),as well as Pittsburgh Sleep Quality Index (PSQI) scores and heart rate variability were compared before and after treatment between the two groups. Correlation analysis was conducted to evaluate the relationship between Lp(a),PSQI scores,and heart rate variability after treatment in both groups,along with the incidence of adverse reactions. Results After treatment,the serum Lp(a),CHO,and LDL-C levels in the treatment group were significantly lower than before treatment (P < 0.01 or 0.05),but no statistically significant difference was found between the two groups (P > 0.05). The PSQI scores in both groups were significantly reduced compared to before treatment,with the treatment group showing a more significant decrease than the control group (P < 0.05). In the treatment group,standard deviation of the averages of 5-minute RR interval (SDANN), standard deviation of RR interval (SDNN), and the root mean square of the difference between adjacent RR interval (rMSSD) were significantly higher compared to both before treatment and the control group at the same time,with statistical significance (P < 0.01 or 0.05). After treatment, there was no correlation between Lp(a) levels and SDANN, SDNN, or rMSSD. PSQI scores were negatively correlated with SDANN, SDNN, and rMSSD (P < 0.01). Conclusions Ozone autohemotherapy has a regulatory effect on lipid metabolism and autonomic nervous function in postmenopausal women. The improvement in autonomic nervous function may be associated with the enhancement of sleep quality.
Mengqi XU , Aijun. ZHANG . The effect of ozone autohemotherapy on serum Lp(a),sleep quality,and heart rate variability in postmenopausal patients with hypercholesterolemia[J]. The Journal of Practical Medicine, 2025 , 41(24) : 3913 -3919 . DOI: 10.3969/j.issn.1006-5725.2025.24.016
| [1] | PRASAD K, MISHRA M. Mechanism of Hypercholesterolemia-Induced Atherosclerosis[J]. Rev Cardiovasc Med, 2022, 23(6): 212. doi:10.31083/j.rcm2306212 |
| [2] | KOZAROVA M, LACKOVA A, KOZELOVA Z, et al. Lipoprotein (a): A Novel Cardiovascular Risk Factor[J]. Balkan Med J, 2023, 40(4): 234-235. doi:10.4274/balkanmedj.galenos.2023.2023-4-8 |
| [3] | 陈俊俊, 王耀振, 卢泽原, 等. 阿托伐他汀联合氯吡格雷在冠心病心绞痛治疗中对血脂、血液流变学及心功能的影响[J]. 中国老年学杂志, 2023, 43(7): 1546-1549. |
| [4] | SZAREK M, BITTNER V A, AYLWARD P, et al. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial[J]. Eur Heart J, 2020, 41(44): 4245-4255. doi:10.1093/eurheartj/ehaa649 |
| [5] | VOLGMAN A S, KOSCHINSKY M L, MEHTA A, et al. Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk[J]. J Am Heart Assoc, 2024, 13(12): e033654. doi:10.1161/jaha.123.033654 |
| [6] | TAI B W S, DAWOOD T, MACEFIELD V G, et al. The association between sleep duration and muscle sympathetic nerve activity[J]. Clin Auton Res, 2023, 33(6): 647-657. doi:10.1007/s10286-023-00965-7 |
| [7] | 侯静, 李欢, 王蕾, 等. 免疫三氧自体血回输联合他汀类降脂药物治疗急性缺血性脑血管病的效果及对低密度脂蛋白胆固醇水平的影响[J]. 中国现代药物应用, 2023, 17(22): 95-98. |
| [8] | 中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中华心血管病杂志, 2023, 51(3): 221-255. |
| [9] | GOUNI-BERTHOLD I, LAUFS U. Special Aspects of Cholesterol Metabolism in Women[J]. Dtsch Arztebl Int, 2024, 121(12): 401-406. |
| [10] | CHO S M J, LEE H J, SHIM J S, et al. Associations between age and dyslipidemia are differed by education level: The Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort[J]. Lipids Health Dis, 2020, 19: 12. doi:10.1186/s12944-020-1189-y |
| [11] | 冯国飞, 纪禹同, 袁慧, 等. 成人心血管发病风险评估及其血脂达标情况分析[J]. 实用医学杂志, 2020, 36(4): 502-506. |
| [12] | 方梦辰, 张培珍. 运动对围绝经期和绝经后妇女心率变异性的调节[J]. 中南大学学报(医学版), 2024, 49(4): 516-525. |
| [13] | HARAPAN B N, HARAPAN T. The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): A review[J]. Med Gas Res, 2023, 13(4): 165-171. doi:10.4103/2045-9912.369237 |
| [14] | RE L. Ozone in Medicine: A Few Points of Reflections[J]. Front Physiol, 2022, 13: 842229. doi:10.3389/fphys.2022.842229 |
| [15] | 陆青竹, 洪小娟, 曾威. 高压臭氧大自血疗法治疗冠心病心绞痛的疗效研究[J]. 临床医学工程, 2020, 27(10): 1333-1334. |
| [16] | BLAHA M J, BHATIA H S. Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy[J]. J Am Coll Cardiol, 2024, 83(16): 1540-1542. doi:10.1016/j.jacc.2024.03.370 |
| [17] | REHBERGER LIKOZAR A, ZAVRTANIK M, ?EBE?TJEN M. Lipoprotein(a) in atherosclerosis: From pathophysiology to clinical relevance and treatment options[J]. Ann Med, 2020, 52(5): 162-177. doi:10.1080/07853890.2020.1775287 |
| [18] | NICHOLLS S J. Therapeutic Potential of Lipoprotein(a) Inhibitors[J]. Drugs, 2024, 84(6): 637-643. doi:10.1007/s40265-024-02046-z |
| [19] | TOMIC NAGLIC D, MANOJLOVIC M, PEJAKOVIC S, et al. Lipoprotein(a): Role in atherosclerosis and new treatment options[J]. Biomol Biomed, 2023, 23(4): 575-583. doi:10.17305/bb.2023.8992 |
| [20] | MALOBERTI A, FABBRI S, COLOMBO V, et al. Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option[J]. Int J Mol Sci, 2022, 24(1): 170. doi:10.3390/ijms24010170 |
| [21] | WANG X, LI J, JU J, et al. Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis[J]. Pharmacol Res, 2021, 163: 105275. doi:10.1016/j.phrs.2020.105275 |
| [22] | TANDON V R, SHARMA S, MAHAJAN A, et al. Menopause and Sleep Disorders[J]. J Midlife Health, 2022, 13(1): 26-33. doi:10.4103/jmh.jmh_18_22 |
| [23] | SHEN W, LIU N, JI Z, et al. Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study[J]. Pain Res Manag, 2022, 2022: 3562191. doi:10.1155/2022/3562191 |
| [24] | FERNáNDEZ-CUADROS M E, ALBALADEJO-FLORíN M J, PE?A-LORA D, et al. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage[J]. SN Compr Clin Med, 2020, 2(8): 1094-1102. doi:10.1007/s42399-020-00328-7 |
| [25] | SCHLAGINTWEIT J, LAHARNAR N, GLOS M, et al. Effects of sleep fragmentation and partial sleep restriction on heart rate variability during night[J]. Sci Rep, 2023, 13: 6202. doi:10.1038/s41598-023-33013-5 |
| [26] | 马随随, 温昌明, 贾艳露, 等. 椎-基底动脉系统及颈内动脉系统狭窄患者睡眠质量、结构与心率变异性的关系研究[J]. 中华神经医学杂志, 2025,24(4):362-369. |
/
| 〈 |
|
〉 |